A clinical study of CAR-Treg in the prevention of chronic rejection after organ transplantation.

Trial Profile

A clinical study of CAR-Treg in the prevention of chronic rejection after organ transplantation.

Planning
Phase of Trial: Phase I

Latest Information Update: 28 Jun 2017

At a glance

  • Drugs CAR Tregs-TxCell (Primary)
  • Indications Transplant rejection
  • Focus Adverse reactions; First in man
  • Most Recent Events

    • 28 Jun 2017 New trial record
    • 19 Jun 2017 According to a TxCell media release, this trial is expected to initiate by the end of 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top